Leucovorin calcium

亚叶酸钙

Report date: 2026/02/06 20:01:23
NME

Base Information

Drug NameLeucovorin calcium
Drug Alias Name醛氢叶酸Rescuvolin甲酰四氢叶酸钙calcii folinasCalcium Folinate +[21] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA synthesis inhibitorsThymidylate synthase inhibitors
TargetsThymidylate synthase
Therapy Area/IndicationsFolic Acid DeficiencyAnemiaColorectal Neoplasms
Global Approved IndicationsAnemia
Approved Indications in ChinaAnemia
Original Approved Country/TerritoryUnited States
Original Approved Date1952/06/20
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesAvyxa Holdings LLCKaifeng Kangnuo Pharmaceutical Co Ltd
Inactive CompaniesHospira Inc
Active IndicationsFolic Acid DeficiencyAnemiaColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeV03AF03
Related LinksWikipediaDrugBankKEGG